Eagle Health Investments LP Sarepta Therapeutics, Inc. Transaction History
Eagle Health Investments LP
- $538 Million
- Q1 2024
A detailed history of Eagle Health Investments LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Eagle Health Investments LP holds 103,256 shares of SRPT stock, worth $16.3 Million. This represents 2.48% of its overall portfolio holdings.
Number of Shares
103,256
Previous 189,356
45.47%
Holding current value
$16.3 Million
Previous $18.3 Million
26.79%
% of portfolio
2.48%
Previous 3.71%
Shares
5 transactions
Others Institutions Holding SRPT
# of Institutions
470Shares Held
79.3MCall Options Held
4.23MPut Options Held
1.21M-
Vanguard Group Inc Valley Forge, PA8.8MShares$1.39 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.96MShares$942 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X04.89MShares$773 Million0.36% of portfolio
-
Capital International Investors Los Angeles, CA4.82MShares$761 Million0.13% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.34MShares$686 Million6.78% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $13.8B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...